An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure.
Esler
Murray
M
D000978:Antiparkinson Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000188:drug therapy*; D015103:Droxidopa / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D013575:Syncope / Q000188:drug therapy
D000978:Antiparkinson Agents; D015103:Droxidopa